Updated: 23 hours ago
Medically reviewed by Dr Eric Wang- ChinaCureLink Team
A diagnosis changes everything. Understand your options, connect with the right specialists, and plan your cancer treatment in China with support from ChinaCureLink at every step, from your first report to your follow-up care.
In the past years, China has approved cancer treatments that most countries don't have yet:
The first CAR-T cell therapy for a solid tumor (for stomach cancer),
An immunotherapy that outlived Keytruda head-to-head in lung cancer, and several other new drugs.
For patients who may run out of options at home, these are real reasons to look at China.
The most important first step is finding out whether any of them fits your diagnosis — before you book a flight.
Table of Contents
Why International Patients Are Looking at China
China has the world's largest cancer patient population, and that scale has driven fast, large clinical trials of Chinese-developed drugs. Several of these have now been approved in China ahead of the US and Europe. Some, like the lung cancer drug sunvozertinib, have since been approved by the US FDA too.
What China offers is not "better cancer care" across the board. Standard care at leading centers is broadly similar worldwide. China's advantage lies in specific approved drugs, cell therapies and trials that may not be available, or affordable, where you live. Hainan's Boao Lecheng medical zone adds another route: it can provide some drugs approved overseas but not yet in mainland China, and has introduced more than 500 such drugs and devices (Xinhua, Jan 2026).
China's Most Important Cancer Advances, by Cancer Type
Stomach cancer: the first approved CAR-T for a solid tumor. In June 2026, China approved satri-cel for Claudin18.2-positive, HER2-negative advanced stomach cancer after at least two prior treatments. In its randomized trial, led at Peking University Cancer Hospital, median survival was 7.92 vs. 5.49 months and 22% of patients had tumor shrinkage (CancerNetwork, 2025). It is a meaningful but modest gain, not a cure for most. → Stomach Cancer Treatment in China
Lung cancer: a new immunotherapy that beat pembrolizumab. In the HARMONi-2 phase III trial, ivonescimab achieved median overall survival of 30.8 vs. 22.6 months compared with pembrolizumab (Keytruda) in PD-L1-positive advanced lung cancer without EGFR or ALK alterations (ASCO Post, Sept 2026). It's approved in China. → Lung Cancer Treatment in China
Breast cancer: new ADCs and targeted drugs. In HER2-positive metastatic breast cancer, the Chinese ADC trastuzumab rezetecan achieved median progression-free survival of 30.6 vs. 8.3 months in a phase III trial (ASCO Post, Aug 2026). For triple-negative disease, sacituzumab tirumotecan was approved in China in 2024. → Breast Cancer Treatment in China
Blood cancers: deep CAR-T experience. China runs one of the world's largest CAR-T research programs for leukemia, lymphoma and myeloma, including newer targets such as CD7 for T-cell leukemia. → Best CAR-T Hospitals in China 2026
After standard options: vaccines and cell therapy. Personalized cancer vaccines, DC vaccines and TIL therapy are being studied in China, sometimes accessible through trials or Boao Lecheng. For most solid tumors these remain investigational. → DC Vaccine Therapy in China · Lung Cancer TIL Therapy · Clinical Trials in China for Foreigners
Where These Advances Happen
China's strongest cancer research is concentrated in a handful of academic centers in Beijing, Shanghai and Guangzhou.
Each leads in specific cancers, so the right hospital depends on your diagnosis. → Top 5 Cancer Centers in China · Top 3 Cancer Hospitals in Shanghai · Guangzhou Cancer Hospitals: How to Choose
Peking University Cancer Hospital
Shanghai East Hospital, Tongji University
Sun Yat-sen Memorial Hospital
Specialists Behind the Research
Advanced Cancer Care Exists. Accessing It Is the Real Challenge
Before arranging treatment abroad, make sure these practical questions have clear answers:
Which team treats my particular cancer and biomarker profile?
What records and pathology materials must I send?
Is the treatment route open to an international patient?
How can I arrange an appointment before booking travel?
Which tests, medicines and hospital charges are in the estimate?
Who can interpret during important medical discussions?
What visa and accommodation arrangements will I need?
How will my care continue once I return home?
Each of these can be solved by a determined patient or family. Together, they are why many choose to have help. → How to Join a Cancer Clinical Trial in China · Cancer Treatment Cost in China · China Medical Visa Guide
You Contact the Hospital vs. via ChinaCureLink
Both routes can work. Many large Chinese hospitals have international departments, and some patients go direct. Here is what each route looks like, step by step.
When going direct may be enough: you have lived in China, you can handle records and communication, and you mainly need an appointment. When guided help adds most: you're unsure which treatment or hospital fits, your case is complex or rare, you want a specialist's opinion before deciding to travel, or you prefer to have an on-site medical interpretor and guide.
How Much Does Cancer Treatment in China Cost?
Most international patients should budget about US$20,000–$50,000 for solid tumor treatment, and US$80,000 or more for advanced blood cancer treatment such as CAR-T or a stem cell transplant. These are typical ranges for a course of treatment at a leading hospital, not quotes. Your actual cost depends on your diagnosis and plan.
What a hospital quote usually covers: treatment, medicines given in hospital, scans and tests during treatment, and your inpatient stay. What it often leaves out: take-home drugs, treatment of complications, extra cycles if your plan changes, and your travel, hotel and caregiver costs. Always ask for an itemized estimate and what is excluded.
Ways to keep costs predictable:
Get a written estimate before you travel, based on your actual records.
Ask about international patient discounts. When a hospital sends you a quote, ChinaCureLink helps you apply for any international patient discount it offers.
Budget for long-term drugs. Many newer drugs are taken for months. If a drug is approved only in China, plan how you'll pay for and receive refills after you return home.
Check your insurance. Most international health plans don't cover treatment in China, and China's national insurance doesn't cover foreign patients.
Advanced Cancer Treatment Options in China
Explore the treatment guides below. Suitability, approval status and access depend on your diagnosis and specialist review.
The Bottom Line
China now offers several cancer treatments that are hard to get elsewhere, backed by published phase III trials and, in some cases, world-first approvals. Each helps a specific group of patients. The safest way to start is to have your diagnosis, biomarkers and treatment history reviewed before you decide to travel.
Get a Second Opinion
For suitable cases, ChinaCureLink can then coordinate an online consultation with the specialist to discuss the technical treatment details directly. The purpose is to help the patient understand which treatment option and which specialist center may be most appropriate before making an international treatment decision.
What Patients Say About ChinaCureLink & Medebound HEALTH
China CureLink operates under Medebound HEALTH — an internationally recognized healthcare navigation company incorporated in New York 10 years ago, with operations across North America and Asia-Pacific.
Frequently Asked Questions
Is Cancer Treatment in China Better than in the US or Europe?
Not across the board. China's advantage is in specific approved drugs and cell therapies, such as satri-cel for stomach cancer or ivonescimab for lung cancer, that may not be available elsewhere yet.
Can Foreigners Get Cancer Treatment in China?
Yes. Major hospitals treat international patients. Access to clinical trials and special-access programs is more limited and must be confirmed case by case.
What Does ChinaCureLink Charge?
Hospital and specialist matching is free. A video second opinion is a paid consultation, with the fee confirmed before booking. A moderate on-site service fee applies only if you travel. We also help you apply for an international discount on the quote you receive from the hospital.
About ChinaCureLink
ChinaCureLink helps patients across the world access the best cancer treatment at China's top hospitals, without the delays, language barriers, and administrative confusion that typically come with seeking care abroad.
We connect patients directly with China's top cancer hospitals, ensuring that from the first case submission through to treatment and follow-up, every step is guided, translated, and coordinated by a team experienced in cross-border patient care.
ChinaCureLink is proudly affiliated with Medebound HEALTH — founded by US physicians, with over 10 years of experience and more than 3,000 patients served worldwide, Medebound HEALTH is recognized by Forbes and it is one of the most trusted patient cross-border concierge service company across North America and the Asia Pacific.
References
ChinaCureLink internal treatment-budget estimates, supplied November 2026: US$20,000–$50,000 for solid tumors; US$80,000+ for advanced blood cancers. Planning ranges, not individual hospital quotes.
Disclaimer
This article is for informational purposes only and is not medical or financial advice. Treatment eligibility, protocols, and costs vary by individual case — confirm specifics with a coordinator and treating physician before making any decisions.
